330 related articles for article (PubMed ID: 19445363)
21. New treatments of sickle cell disease.
Embury SH
West J Med; 1996 May; 164(5):444. PubMed ID: 8686307
[No Abstract] [Full Text] [Related]
22. Hodgkin's disease in a child with sickle cell disease treated with hydroxyurea.
Moschovi M; Psychou F; Menegas D; Tsangaris GT; Tzortzatou-Stathopoulou F; Nicolaidou P
Pediatr Hematol Oncol; 2001 Sep; 18(6):371-6. PubMed ID: 11554231
[TBL] [Abstract][Full Text] [Related]
23. Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy.
Iyamu EW; Cecil R; Parkin L; Woods G; Ohene-Frempong K; Asakura T
Br J Haematol; 2005 Nov; 131(3):389-94. PubMed ID: 16225659
[TBL] [Abstract][Full Text] [Related]
24. Nitric oxide production from hydroxyurea.
King SB
Free Radic Biol Med; 2004 Sep; 37(6):737-44. PubMed ID: 15304249
[TBL] [Abstract][Full Text] [Related]
25. Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy.
Lanaro C; Franco-Penteado CF; Albuqueque DM; Saad ST; Conran N; Costa FF
J Leukoc Biol; 2009 Feb; 85(2):235-42. PubMed ID: 19004988
[TBL] [Abstract][Full Text] [Related]
26. Sickle cell disease vasculopathy: a state of nitric oxide resistance.
Wood KC; Hsu LL; Gladwin MT
Free Radic Biol Med; 2008 Apr; 44(8):1506-28. PubMed ID: 18261470
[TBL] [Abstract][Full Text] [Related]
27. New therapies in sickle cell disease.
Vichinsky E
Lancet; 2002 Aug; 360(9333):629-31. PubMed ID: 12241949
[TBL] [Abstract][Full Text] [Related]
28. Pathophysiology and therapy for haemoglobinopathies. Part I: sickle cell disease.
Madigan C; Malik P
Expert Rev Mol Med; 2006 Apr; 8(9):1-23. PubMed ID: 16690007
[TBL] [Abstract][Full Text] [Related]
29. [Management of sickle cell disease].
de Montalembert M
Rev Prat; 2004 Sep; 54(14):1557-64. PubMed ID: 15558966
[TBL] [Abstract][Full Text] [Related]
30. Effects of hydroxyurea on malaria, parasite growth and adhesion in experimental models.
Pino P; Taoufiq Z; Brun M; Tefit M; Franetich JF; Ciceron L; Krishnamoorthy R; Mazier D
Parasite Immunol; 2006 Dec; 28(12):675-80. PubMed ID: 17096647
[TBL] [Abstract][Full Text] [Related]
31. Modulation of erythroid adhesion receptor expression by hydroxyurea in children with sickle cell disease.
Odièvre MH; Bony V; Benkerrou M; Lapouméroulie C; Alberti C; Ducrocq R; Jacqz-Aigrain E; Elion J; Cartron JP
Haematologica; 2008 Apr; 93(4):502-10. PubMed ID: 18322255
[TBL] [Abstract][Full Text] [Related]
32. Advances in clinical research in sickle cell disease.
Hagar W; Vichinsky E
Br J Haematol; 2008 May; 141(3):346-56. PubMed ID: 18341629
[TBL] [Abstract][Full Text] [Related]
33. [Pathophysiology of sickle cell disease].
Elion J; Laurance S; Lapouméroulie C
Med Trop (Mars); 2010 Dec; 70(5-6):454-8. PubMed ID: 21520646
[TBL] [Abstract][Full Text] [Related]
34. [Sickle cell disease in childhood in 2004].
Girot R; Bégué P
Bull Acad Natl Med; 2004; 188(3):491-505; discussion 505-6. PubMed ID: 15584658
[TBL] [Abstract][Full Text] [Related]
35. Prevention of red cell dehydration: a possible new treatment for sickle cell disease.
Mueller BU; Brugnara C
Pediatr Pathol Mol Med; 2001; 20(1):15-25. PubMed ID: 12673842
[TBL] [Abstract][Full Text] [Related]
36. Pathophysiological-based approaches to treatment of sickle cell disease.
Steinberg MH; Brugnara C
Annu Rev Med; 2003; 54():89-112. PubMed ID: 12359829
[TBL] [Abstract][Full Text] [Related]
37. Hydroxyurea improves nitric oxide bioavailability in humanized sickle cell mice.
Taylor CM; Kasztan M; Sedaka R; Molina PA; Dunaway LS; Pollock JS; Pollock DM
Am J Physiol Regul Integr Comp Physiol; 2021 May; 320(5):R630-R640. PubMed ID: 33624556
[TBL] [Abstract][Full Text] [Related]
38. Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea.
Cartron JP; Elion J
Transfus Clin Biol; 2008; 15(1-2):39-50. PubMed ID: 18515167
[TBL] [Abstract][Full Text] [Related]
39. [Physiopathology and treatment of sickle cell anemia].
Adjaoud D
Soins Pediatr Pueric; 2007 Feb; (234):16-8. PubMed ID: 17338411
[No Abstract] [Full Text] [Related]
40. Sickle cell disease; a general overview.
Schnog JB; Duits AJ; Muskiet FA; ten Cate H; Rojer RA; Brandjes DP
Neth J Med; 2004 Nov; 62(10):364-74. PubMed ID: 15683091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
